Showing results 12 to 31 of 71
< previous
next >
| Preview | Issue Date | Title | Author(s) |
| 2006 | Calpain inhibitors and compositions | Abell, A.; Neffe, A.; Stuart, B.; Lee, H.; Morton, J.; Coxon, J.; Nikkel, J.; Robertson, L.; Jones, M.; Muir, M.; Bickerstaffe, R.; Miyamoto, S.; Aitken, S. |
| 2010 | Calpains: Attractive targets for the development of synthetic inhibitors | Pietsch, M.; Chua, K.; Abell, A. |
| 2006 | Compounds and compositions | Abell, A.; Neffe, A.; Stuart, B.; Lee, H.; Morton, J.; Coxon, J.; Nikkel, J.; Duncan, J.; Robertson, L.; Jones, M.; Muir, M.; Klanchantra, M.; Bickerstaffe, R.; McNabb, S.; Aitken, S. |
| 2004 | Conformationally constrained beta-amino acids | Anderson, K.; Gardiner, J.; Abell, A.; Flegel, M.; Fridkin, M.; Gilon, C.; Slaninova, J.; International Peptide Symposium & European Peptide Symposium (3rd & 28th : 2004 : Prague, Czech Republic) |
| 2003 | Cross metathesis of nitrogen-containing systems | Vernall, A.; Abell, A. |
| 2008 | Cross-metathesis and ring-closing metathesis reactions of amino acid-based substrates | Vernall, A.; Ballet, S.; Abell, A. |
| 2004 | Cross-metathesis coupling of sugars and fatty acids to lysine and cysteine | Vernall, A.; Abell, A. |
| 2001 | Design and synthesis of a conformationally restricted trans peptide isostere based on the bioactive conformations of saquinavir and nelfinavir | Edmonds, M.; Abell, A. |
| 2005 | Design and synthesis of aromatic inhibitors of anthranilate synthase | Payne, R.; Bulloch, E.; Abell, A.; Abell, C. |
| 2005 | Developments in the design and synthesis of calpain inhibitors | Neffe, A.; Abell, A. |
| 2010 | Electrochemistry of ferrocenoyl β-peptide monolayers on gold | Brooksby, P.; Anderson, K.; Downard, A.; Abell, A. |
| 2006 | Estrogenicity of pyrethroid insecticide metabolites | McCarthy, A.; Thomson, B.; Shaw, I.; Abell, A. |
| 2016 | Fluorescent IGF-II analogues for FRET-based investigations into the binding of IGF-II to the IGF-1R | Cottam Jones, J.; Harris, P.; Scanlon, D.; Forbes, B.; Brimble, M.; Abell, A. |
| 2010 | Fluorinated β²- and β³-amino acids: synthesis and inhibition of α-chymotrypsin | Peddie, V.; Pietsch, M.; Bromfield, K.; Pike, R.; Duggan, P.; Abell, A. |
| 2001 | Heterocyclic-based peptidomimetics | Abell, A. |
| 2005 | Inhibition studies on salicylate synthase | Payne, R.; Kerbarh, O.; Miguel, R.; Abell, A.; Abell, C. |
| 2004 | Inhibitors of types I and II dehydroquinase | Le Sann, C.; Gower, M.; Abell, A. |
| 2009 | Molecular modeling, synthesis, and biological evaluation of macrocyclic calpain inhibitors | Abell, A.; Jones, M.; Coxon, J.; Morton, J.; Aitken, S.; McNabb, S.; Lee, H.; Mehrtens, J.; Alexander, N.; Stuart, B.; Neffe, A.; Bickerstaffe, R. |
| 2008 | Multiple ligands in opioid research | Ballet, S.; Pietsch, M.; Abell, A. |
| 2013 | New cylindrical peptide assemblies defined by extended parallel β-sheets | Pehere, A.; Sumby, C.; Abell, A. |
